(Q27011595)

30 June 2019

title

Influenza prevention and treatment in transplant recipients and immunocompromised hosts (English)

1 reference

30 June 2019

author name string

Michael G Ison

series ordinal

1

1 reference

30 June 2019

language of work or name

1 reference

1 November 2013

1 reference

30 June 2019

Influenza and Other Respiratory Viruses

published in

1 reference

30 June 2019

volume

7 Suppl 3

1 reference

30 June 2019

page(s)

60-66

1 reference

30 June 2019

Influenza: a recurrent challenge to transplantation

cites work

1 reference

Influenza, including the novel H1N1, in organ transplant patients

21 January 2018

1 reference

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

21 January 2018

1 reference

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients

21 January 2018

1 reference

Influenza vaccination in the organ transplant recipient: review and summary recommendations.

21 January 2018

1 reference

Antivirals and resistance: influenza virus

21 January 2018

1 reference

Guidance on novel influenza A/H1N1 in solid organ transplant recipients.

21 January 2018

1 reference

Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients

21 January 2018

1 reference

Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy

21 January 2018

1 reference

How I treat influenza in patients with hematologic malignancies.

21 January 2018

1 reference

Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity

21 January 2018

1 reference

Outcome of influenza infection managed with oseltamivir in lung transplant recipients

21 January 2018

1 reference

Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection

21 January 2018

1 reference

Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses.

21 January 2018

1 reference

Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study

21 January 2018

1 reference

Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies

21 January 2018

1 reference

Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients

21 January 2018

1 reference

Viral disease prevention after hematopoietic cell transplantation

21 January 2018

1 reference

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology

21 January 2018

1 reference

Influenza vaccination in hematopoietic SCT recipients

21 January 2018

1 reference

The benefit of influenza vaccination after bone marrow transplantation

21 January 2018

1 reference

Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study.

21 January 2018

1 reference

Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients

21 January 2018

1 reference

Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade.

21 January 2018

1 reference

Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study

21 January 2018

1 reference

An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to [...]

21 January 2018

1 reference

Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.

21 January 2018

1 reference

Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients

21 January 2018

1 reference

Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients

21 January 2018

1 reference

Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients

21 January 2018

1 reference

Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine

21 January 2018

1 reference

European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN.

21 January 2018

1 reference

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study

21 January 2018

1 reference

Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009

21 January 2018

1 reference

Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit.

21 January 2018

1 reference

End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease

21 January 2018

1 reference

Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study.

21 January 2018

1 reference

Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives

21 January 2018

1 reference

Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation

21 January 2018

1 reference

Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.

21 January 2018

1 reference

Oseltamivir-resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient

21 January 2018

1 reference

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics

21 January 2018

1 reference

Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus

21 January 2018

1 reference

2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients.

21 January 2018

1 reference

The Clinical Impact of Infection with Swine Flu (H1N109) Strain of Influenza Virus in Hematopoietic Stem Cell Transplant Recipients.

21 January 2018

1 reference

Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT.

21 January 2018

1 reference

Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience

21 January 2018

1 reference

Pandemic influenza (H1N1): impact on lung transplant recipients and candidates

21 January 2018

1 reference

Increased mortality of solid organ transplant recipients with H1N1 infection: a single center experience.

21 January 2018

1 reference

Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study

21 January 2018

1 reference

The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation

21 January 2018

1 reference

Severe H1N1 infection in a pediatric liver transplant recipient treated with intravenous zanamivir: efficiency and complications

21 January 2018

1 reference

Efficient control of pandemic 2009 H1N1 virus infection with intravenous zanamivir despite the lack of immune function

21 January 2018

1 reference

Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus

21 January 2018

1 reference

H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis

21 January 2018

1 reference

Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir

21 January 2018

1 reference

Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir

21 January 2018

1 reference

Peramivir for the treatment of influenza

21 January 2018

1 reference

Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus

21 January 2018

1 reference

Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection.

21 January 2018

1 reference

Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households

21 January 2018

1 reference

Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial

21 January 2018

1 reference

Experimental human influenza: observations from studies of influenza antivirals

21 January 2018

1 reference

DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient

21 January 2018

1 reference

A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection

21 January 2018

1 reference

An update on donor-derived disease transmission in organ transplantation

21 January 2018

1 reference

Influenza viremia and the potential for blood-borne transmission

21 January 2018

1 reference

No viremia of pandemic (H1N1) 2009 was demonstrated in blood donors who had donated blood during the probable incubation period

21 January 2018

1 reference

Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors

21 January 2018

1 reference

Transplantation of solid organs procured from influenza A H1N1 infected donors.

21 January 2018

1 reference

Risk of transmission of H1N1 influenza by solid organ transplantation in the United Kingdom

21 January 2018

1 reference

Influenza B virus transmission in recipients of kidney and lung transplants from an infected donor

21 January 2018

1 reference

The humoral immune response to influenza vaccination in lung transplant patients

21 January 2018

1 reference

Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients

21 January 2018

1 reference

Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation

21 January 2018

1 reference

Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study

21 January 2018

1 reference

A Prospective Molecular Surveillance Study Evaluating the Clinical Impact of Community-Acquired Respiratory Viruses in Lung Transplant Recipients

21 January 2018

1 reference

Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients

21 January 2018

1 reference

Efficacy of influenza vaccination in adult liver transplant recipients

21 January 2018

1 reference

12 December 2020

Influenza transmission to recipient through lung transplantation

1 reference

12 December 2020

Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus.

1 reference

12 December 2020

RNA respiratory viral infections in solid organ transplant recipients

1 reference

12 December 2020

Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.

1 reference

12 December 2020

Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination

1 reference

12 December 2020

Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients

1 reference

12 December 2020

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season

1 reference

12 December 2020

Identifiers

DOI

10.1111/IRV.12170

1 reference

30 June 2019

PMC publication ID

6492654

1 reference

30 June 2019

PubMed publication ID

24215383

1 reference

30 June 2019